Hematology/Oncology

Top Story

Single adjuvant chemotherapy course safe, effective for high-risk testicular cancer

February 17, 2020
FDA News

FDA grants priority review to lurbinectedin for relapsed small cell lung cancer

February 17, 2020
The FDA granted priority review to lurbinectedin for the treatment of small cell lung cancer that relapsed after platinum-based therapy, according to a press release…
In the Journals

Adolescent, young adult cancer survivors at higher risk for mortality, chronic conditions

February 17, 2020
Survivors of cancer diagnosed during adolescence or early adulthood appeared at greater risk for mortality and severe chronic health conditions compared with the general…
In the Journals

Algorithm-based apps show poor performance in detecting skin cancer

February 17, 2020
Smartphone applications that use algorithms to assess the risk for skin cancer appear to have poor and variable performance, according to a systematic review of…
In the Journals

Less-intensive treatment regimen effective for certain children with B-cell ALL

February 17, 2020
An antimetabolite-based regimen with low myelosuppressive activity may be capable of eradicating a subset of pediatric B-cell acute lymphoblastic leukemia, according to…
More Headlines »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next